Average Co-Inventor Count = 5.93
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vtv Therapeutics LLC (10 from 52 patents)
2. High Point Pharmaceuticals, LLC (7 from 50 patents)
3. Transtech Pharma, Inc. (2 from 49 patents)
19 patents:
1. 11970457 - Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amine
2. 11524942 - Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amine
3. 10568888 - Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
4. 10391097 - Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
5. 10364233 - Piperidine derivative and methods of use thereof
6. 10085990 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
7. 9833457 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
8. 9687489 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
9. 9393245 - Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
10. 9163022 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
11. 8853226 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
12. 8563742 - Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
13. 8450354 - Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as β-secretase inhibitors
14. 8350039 - Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
15. 8329715 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors